Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 241
Filter
1.
Asian Journal of Andrology ; (6): 479-483, 2021.
Article in English | WPRIM | ID: wpr-888459

ABSTRACT

The novel coronavirus disease (COVID-19) pandemic is emerging as a global health threat and shows a higher risk for men than women. Thus far, the studies on andrological consequences of COVID-19 are limited. To ascertain the consequences of COVID-19 on sperm parameters after recovery, we recruited 41 reproductive-aged male patients who had recovered from COVID-19, and analyzed their semen parameters and serum sex hormones at a median time of 56 days after hospital discharge. For longitudinal analysis, a second sampling was obtained from 22 of the 41 patients after a median time interval of 29 days from first sampling. Compared with controls who had not suffered from COVID-19, the total sperm count, sperm concentration, and percentages of motile and progressively motile spermatozoa in the patients were significantly lower at first sampling, while sperm vitality and morphology were not affected. The total sperm count, sperm concentration, and number of motile spermatozoa per ejaculate were significantly increased and the percentage of morphologically abnormal sperm was reduced at the second sampling compared with those at first in the 22 patients examined. Though there were higher prolactin and lower progesterone levels in patients at first sampling than those in controls, no significant alterations were detected for any sex hormones examined over time following COVID-19 recovery in the 22 patients. Although it should be interpreted carefully, these findings indicate an adverse but potentially reversible consequence of COVID-19 on sperm quality.


Subject(s)
Adult , Humans , Male , Asthenozoospermia/virology , COVID-19/physiopathology , China , Gonadal Steroid Hormones/blood , Progesterone/blood , Prolactin/blood , SARS-CoV-2 , Semen/physiology , Semen Analysis , Sperm Count , Sperm Motility , Spermatozoa/physiology , Time Factors
2.
Rev. chil. obstet. ginecol. (En línea) ; 85(6): 697-708, dic. 2020. tab
Article in Spanish | LILACS | ID: biblio-1508031

ABSTRACT

INTRODUCCÍÓN Y OBJETIVOS: El embarazo ectópico es una condición potencialmente mortal, con una incidencia del 1 al 2%. El 97% se produce en las tubas uterinas, y el 80% de éstos se encuentran en la región ampular. El objetivo de esta revisión es exponer una actualización del enfrentamiento y manejo del embarazo ectópico tubario. MÉTODOS: Mediante el uso de la base de datos Epistemonikos, Scielo, Cochrane y Pubmed, se revisó la literatura existente sobre embarazo ectópico tubario. RESULTADOS: El diagnóstico de embarazo ectópico tubario implica una combinación de síntomas clínicos, serología y ultrasonido. El manejo médico es una opción segura y efectiva en la mayoría de las pacientes hemodinámicamente estables. En caso de fracaso de tratamiento médico, paciente incapaz de mantener seguimiento, embarazo ectópico roto o embarazo heterotópico, debe ser manejado con tratamiento quirúrgico idealmente por laparoscopía. Independiente del tratamiento utilizado, existe gran probabilidad de éxito y escasas complicaciones. CONCLUSIONES: Esta actualización describe la incidencia, factores de riesgo, diagnóstico, y manejo del embarazo ectópico tubario. Es importante un diagnóstico y tratamiento temprano, para reducir complicaciones asociadas a esta patología.


INTRODUCTION AND OBJECTIVES: Ectopic pregnancy is a potencially lethal condition, it has an incidence of 1-2%. 97% occurs in uterine tubes, and 80% in the ampulla. The objetive of this review is to update management of this pathology. METHODS: Existent literature was reviewed in different data base: Epistemonikos, Scielo, Cochrane and Pubmed. RESULTS: Tubal Ectopic Pregnancy Diagnostic implies a combination of clinical features, serology and ultrasound. Medical management is a safe and effective alternative in most of hemodinamically stable patients. When medical treatment fails, or patient is not able to stay in observation, or ectopic/heterotopic pregnancy is diagnosed, surgical management is needed specially by laparoscopy. Regardless of the treatment, there is a high chance of success and low rate of complications. CONCLUSIONS: This update describes incidence, risk factors, diagnostic and management of tubal ectopic pregnancy. An early diagnostic and treatment are crucial to reduce complications due to this pathology.


Subject(s)
Humans , Female , Pregnancy , Pregnancy, Ectopic/diagnosis , Pregnancy, Ectopic/therapy , Pregnancy, Ectopic/blood , Progesterone/blood , Methotrexate/therapeutic use , Risk Factors , Ultrasonography/methods , Salpingectomy , Chorionic Gonadotropin/blood
3.
Rev. bras. ginecol. obstet ; 41(9): 525-530, Sept. 2019. tab, graf
Article in English | LILACS | ID: biblio-1042339

ABSTRACT

Abstract Objective The etiology of embryonic demise is multifactorial, with chromosomal abnormalities being the most common (40%). The purpose of the present study is to evaluate the correlation between a serum biomarker, progesterone, and an ultrasonographic parameter, the distance between yolk sac and embryo (DYSE) in assessing the prognosis of pregnancy outcome in the 1st trimester. Methods The present study is a prospective case-control analysis that includes 2 groups of patients: 81 patients with first-trimester normal evolutive pregnancy and 89 patients with embryonic demise, all of the patients having between 6 and 11 weeks of amenorrhea. Endovaginal ultrasonographic exploration was performed to evaluate the distance between the lower pole of the embryo and the yolk sac. From each subject enrolled in the study, 20ml of blood was collected for progesterone serum level measurement. Results Regarding the DYSE in the case group, lower values were observed compared with the control group, the difference being statistically significant. In the statistical analysis of serum progesterone values, statistically significant differences were observed between the 2 groups (p<0.05). Conclusion The DYSE has a high positive predictive value in identifying pregnancies with potentially reserved outcome, with the present study demonstrating that a DYSE<3mm causes an unfavorable evolution of the pregnancy. Low serum levels of progesterone are associated with an increased rate of nonviable embryos. The correlation between these two parameters increases the effectiveness of screening methods in prenatal monitoring and improves the diagnostic methods for the firsttrimester pregnancies whose outcome potential can be reserved.


Subject(s)
Humans , Female , Pregnancy , Pregnancy Trimester, First/physiology , Pregnancy Trimester, First/blood , Progesterone/blood , Pregnancy Outcome/epidemiology , Ultrasonography, Prenatal , Prognosis , Yolk Sac/diagnostic imaging , Case-Control Studies , Embryo, Mammalian/diagnostic imaging
4.
Trends psychiatry psychother. (Impr.) ; 41(2): 136-143, Apr.-June 2019. tab
Article in English | LILACS | ID: biblio-1014737

ABSTRACT

Abstract Objective To assess the relationship between sexual hormones, sexual function and quality of life in postmenopausal women. Method A cross-sectional study was conducted with a convenience sample of 36 postmenopausal women between the ages of 45 and 65 in follow-up at a climacteric outpatient clinic. Mood, quality of life, sexual function and hormonal profile were assessed. Results With regard to sexual hormones and sexual function, a relationship was found between orgasm and luteinizing hormone (r=0.37), orgasm and sex hormone-binding globulin (SHBG) (r=0.39), SHBG and less pain (r=0.44), dehydroepiandrosterone (DHEA) and desire (r=-0.45), as well as between prolactin and lubrication (r=0.33). Sexual hormones and quality of life were related as follows: progesterone and limitations due to physical aspects (r=0.35), SHBG and social aspects (r=0.35), cortisol and pain (r=0.46), DHEA and social aspects (r=-0.40). Finally, the following relationships were found between sexual function and quality of life: sexual desire and vitality, social aspects, state of general health and mental health (r=0.46, r=0.51, r=0.35, and r=0.38, respectively). Arousal, orgasm and satisfaction with sexual life showed a relationship with less physical pain (r=0.40, r=0.42, and r=0.43, respectively). Satisfaction with sexual life was correlated with vitality (r=0.33). Conclusion Different correlations than expected were found in this study regarding the effect of some hormones on sexual function and some aspects of the quality of life of postmenopausal women.


Resumo Objetivo Avaliar a relação entre hormônios sexuais, função sexual e qualidade de vida em mulheres na pós-menopausa. Métodos Estudo transversal com amostra de conveniência de 36 mulheres na pós-menopausa, com idades entre 45 e 65 anos, em seguimento ambulatorial de climatério. Humor, qualidade de vida, função sexual e perfil hormonal foram avaliados. Resultados Entre hormônios sexuais e função sexual, foi encontrada relação entre orgasmo e hormônio luteinizante (r=0,37), orgasmo e globulina ligadora de hormônios sexuais (SHBG) (r=0,39), SHBG e menos dor (r=0,44), desidroepiandrosterona (DHEA) e desejo (r=-0,45), bem como entre prolactina e lubrificação (r=0,33). Entre hormônios sexuais e qualidade de vida: progesterona e limitações por aspectos físicos (r=0,35), SHBG e aspectos sociais (r=0,35), cortisol e dor (r=0,46), DHEA e aspectos sociais (r=-0,40). Por fim, entre função sexual e qualidade de vida: desejo sexual e vitalidade, aspectos sociais, estado geral de saúde e saúde mental (r=0,46, r=0,51, r=0,35 e r=0,38, respectivamente). Excitação, orgasmo e satisfação com a vida sexual mostraram uma relação com menos dor física (r=0,40, r=0,42 e r=0,43, respectivamente). A satisfação com a vida sexual foi correlacionada com a vitalidade (r=0,33). Conclusão Correlações diferentes das esperadas foram encontradas neste estudo em relação ao efeito de alguns hormônios sobre a função sexual e alguns aspectos da qualidade de vida de mulheres na pós-menopausa.


Subject(s)
Humans , Female , Aged , Quality of Life/psychology , Sexual Behavior/psychology , Postmenopause/psychology , Postmenopause/blood , Orgasm/physiology , Personal Satisfaction , Progesterone/blood , Sex Hormone-Binding Globulin/analysis , Luteinizing Hormone/blood , Cross-Sectional Studies , Surveys and Questionnaires , Dehydroepiandrosterone/blood , Middle Aged
5.
Clinics ; 74: e1111, 2019. graf
Article in English | LILACS | ID: biblio-1039561

ABSTRACT

Pregnancy of unknown location is a situation in which a positive pregnancy test occurs, but a transvaginal ultrasound does not show intrauterine or ectopic gestation. One great concern of pregnancy of unknown location is that they are cases of ectopic pregnancy whose diagnosis might be postponed. Transvaginal ultrasound is able to identify an ectopic pregnancy with a sensitivity ranging from 87% to 94% and a specificity ranging from 94% to 99%. A patient with pregnancy of unknown location should be followed up until an outcome is obtained. The only valid biomarkers with clinical application and validation are serum levels of the beta fraction of hCG and progesterone. A single serum dosage of hCG is used only to determine whether the value obtained is above or below the discriminatory zone, that means the value of serum hCG above which an intrauterine gestational sac should be visible on ultrasound. Serum progesterone levels are a satisfactory marker of pregnancy viability, but they are unable to predict the location of a pregnancy of unknown location: levels below 5 ng/mL are associated with nonviable gestations, whereas levels above 20 ng/mL are correlated with viable intrauterine pregnancies. Most cases are low risk and can be monitored by expectant management with transvaginal ultrasound and serial serum hCG levels, in addition to the serum progesterone levels. To minimize diagnostic error and intervene during progressive intrauterine gestation, protocol indicates active treatment only in situations when progressive intrauterine pregnancy is excluded and a high possibility of ectopic pregnancy exists.


Subject(s)
Humans , Female , Pregnancy , Pregnancy, Ectopic/diagnosis , Pregnancy, Ectopic/therapy , Progesterone/blood , Chorionic Gonadotropin/blood , Biomarkers/blood , Ultrasonography, Prenatal
6.
Int. j. morphol ; 35(4): 1473-1481, Dec. 2017. tab, graf
Article in English | LILACS | ID: biblio-893159

ABSTRACT

SUMMARY: Special features of nanoparticles have resulted in their widespread use. Small molybdenum trioxide (MoO 3) nanoparticles can translocate from the entry portals into the circulatory and lymphatic systems and ultimately to body tissues and organs depending on their composition and size. In this research, sixty Wistar rats weighting 180-250 g were divided into 6 groups (n=10) randomly: Group 1 (Control) did not receive any medicine. Group 2 (Sham) received intraperitoneal normal saline for 35 days on a daily basis. Groups 3, 4, 5 and 6 received 50, 100, 200, and 300 mg/kg MoO3, respectively, the same way in the sham group and at the same interval. At the end of the experiment, the rats were weighted again and anesthetised. Then blood samples were taken from their hearts to determine the serum levels of estrogen, progesterone, and gonadotropins. Their ovaries were removed and ovarian volume, follicular diameter, number of each follicle type, and oocyte volume were determined. Results indicated that MoO3 nanoparticles strongly reduced body and ovarian weights in the rats. Moreover, a significant decrease was observed in ovarian volume, the number of follicle types, oocyte volume and follicular diameter. The nanoparticles increased the number of atretic follicles via ovarian tissue structure. MoO3 nanoparticles decreased serum estrogen level and increased serum level of FSH that was associated with disruption in the regulation of progesterone and LH secretion. The findings showed that MoO3 nanoparticles could bear negative effects on ovarian structure and function.


RESUMEN: Las características específicas de las nanopartículas han dado lugar a su uso generalizado. Las pequeñas nanopartículas de trióxido de molibdeno (MoO3) pueden penetrar los sistemas circulatorios y linfáticos y, en última instancia, dependiendo de su composición y tamaño, también los tejidos y órganos del cuerpo. En esta investigación se dividieron 60 ratas Wistar con un peso de 180-250 g en 6 grupos (n = 10) aleatoriamente: el Grupo 1 (Control) no recibió ningún medicamento. El Grupo 2 (Sham) recibió solución salina normal intraperitoneal durante 35 días diariamente. Los grupos 3, 4, 5 y 6 recibieron 50, 100, 200 y 300 mg / kg de MoO3 respectivamente, de la misma manera en el grupo simulado, y en el mismo intervalo. Concluyendo el experimento, las ratas se pesaron nuevamente y fueron anestesiadas. Luego se tomaron muestras de sangre de los corazones para determinar los niveles séricos de estrógeno, progesterona y gonadotropinas. Se retiraron los ovarios y se determinó el volumen ovárico, el diámetro folicular, el número de cada tipo de folículo y el volumen de ovocitos. Los resultados indicaron que las nanopartículas de MoO3 redujeron significativamente los pesos corporal y ovárico en las ratas. Además, se observó una disminución importante en el volumen ovárico, el número de tipos de folículos, el volumen de ovocitos y el diámetro folicular. Las nanopartículas aumentaron el número de folículos auriculares a través de la estructura del tejido ovárico. Las nanopartículas de MoO 3 disminuyeron el nivel sérico de estrógeno y aumentaron el nivel sérico de FSH que se asoció con la interrupción en la regulación de la progesterona y la secreción de LH. Los hallazgos mostraron que las nanopartículas de MoO 3 podrían tener efectos negativos sobre la estructura y la función ovárica.


Subject(s)
Animals , Female , Rats , Molybdenum/administration & dosage , Nanoparticles , Ovarian Follicle/drug effects , Oxygen/administration & dosage , Estrogens/blood , Gonadotropins/blood , Microscopy, Electron , Organ Size/drug effects , Ovary/drug effects , Ovary/ultrastructure , Progesterone/blood , Rats, Wistar
7.
Einstein (Säo Paulo) ; 15(3): 273-277, July-Sept. 2017. tab, graf
Article in English | LILACS | ID: biblio-891414

ABSTRACT

ABSTRACT Objective To evaluate the predictive capacity for pregnancy of the progesterone level on the day of administering human chorionic gonadotropin, in women submitted to assisted reproductive techniques. Methods An observational study with 914 women submitted to assisted reproductive techniques from August 2014 to June 2016. Results Total pregnancy rate was 34.58%; in that, the pregnancy rate in women <35 years, between 35 and 38, and >38 years was, respectively, 42.3%, 38.7% and 16.1% (p<0.001). For embryo transfer in the same cycle, and progesterone of 1.3ng/dL, sensitivity was 4.78%, specificity, 84.18%, accuracy, 56.72%, positive likelihood ratio of 0.3019, and negative likelihood ratio of 1.1312, with receiver operating characteristic curve of 0.46 (95%CI: 0.42-0.49). Conclusion The progesterone level on the day of administering human chorionic gonadotropin of 1.3ng/dL differs from that empirically adopted at the study site (1.7ng/dL), and has a better predictive capacity for pregnancy in the patients studied. However, the low sensitivity of this examination raises questions about its real importance.


RESUMO Objetivo Avaliar a capacidade preditiva para gravidez do valor de progesterona no dia da administração da gonadotrofina coriônica humana em mulheres submetidas às técnicas de reprodução assistida. Métodos Estudo observacional com 914 mulheres submetidas a reprodução assistida de agosto de 2014 até junho de 2016. Resultados Engravidaram 34,58% das mulheres, sendo a taxa de gravidez naquelas >35 anos, entre 35 e 38 anos e >38 anos, respectivamente, de 42,3%, 38,7% e 16,1% (p<0,001). Para o valor de progesterona até 1,3ng/dL visando à transferência embrionária no mesmo ciclo, encontraram-se sensibilidade de 4,78%, especificidade de 84,18%, acurácia de 56,72%, razão de verossimilhança positiva de 0,3019 e razão de verossimilhança negativa de 1,1312, com área sob a curva característica de operação do receptor de 0,46 (IC95%: 0,42-0,49). Conclusão O valor de progesterona no dia da administração de gonadotrofina coriônica humana até 1,3ng/dL difere daquele empiricamente adotado no local do estudo (1,7ng/dL) e apresenta melhor capacidade preditiva para gravidez nas pacientes estudadas. No entanto, a baixa sensibilidade deste exame abre questionamentos sobre sua real importância.


Subject(s)
Humans , Female , Pregnancy , Adult , Progesterone/blood , Reproductive Techniques, Assisted , Chorionic Gonadotropin/administration & dosage , Cross-Sectional Studies , Pregnancy Rate
8.
Braz. j. biol ; 77(2): 347-355, Apr.-June 2017. tab, graf
Article in English | LILACS | ID: biblio-888758

ABSTRACT

Abstract In order to achieve successful captive breeding the Podocnemis expansa, it is necessary to study their reproductive endocrinology. The purpose of this research was to evaluate and characterize plasma concentrations in gonadotrophic, gonadic, corticosterone and prolactin hormones from Giant Amazon Turtles under captive conditions. Blood samples were collected over a 15 month period. The samples were assayed by the use of radioimmunoassay, prolactin, corticosterone, LH, FSH, testosterone, 17β-estradiol and progesterone. We verified significant seasonal pattern increase in 17β-estradiol levels and decrease in progesterone levels in the course of a year, which indicates vitellogenesis. This is related to normal ovarian cycles and possibly to the functional integrity of the hypothalamus-pituitary-gonad axis of captive females. There were negative correlations between testosterone and corticosterone in the male samples, suggestive of stress (management stress) on the reproductive system. The plasma concentrations of gonadotrophic, gonadic, prolactin and corticosterone hormones may be used as a reference for further research and possible therapeutic approaches. The data collected during this research are unprecedented for this species and may serve as a reference for future research regarding the reproductive cycle of this turtle, also allowing reproductive management while in captivity. Information about these hormones must be gathered from wild populations during different periods of the year for better clarification of the reproductive physiology of this species.


Resumo Com o objetivo de obter reprodução em cativeiro de Podocnemis expansa, é necessário reunir o conhecimento a respeito de sua endocrinologia reprodutiva. O objetivo deste trabalho foi avaliar e caracterizar as concentrações plasmáticas de hormônios gonadotróficos, gonadais, corticosterona e prolactina em Tartarugas da Amazônia em condições de cativeiro. Amostras de sangue foram coletadas durante 15 meses. As amostras foram ensaiadas pelo uso de um radioimunoensáio, prolactina, corticosterona, LH, FSH, testosterona, 17β-estradiol e progesterona. Verificou-se aumento de padrão sazonal significativo nos níveis de 17β-estradiol e diminuição dos níveis de progesterona ao longo do ano, o que indica o recrutamento folicular. Isto está relacionado com ciclos ovarianos normais e possivelmente para a integridade funcional do eixo hipotálamo-hipófise-gônadas de fêmeas em cativeiro. Houve correlação negativa entre testosterona e corticosterona nas amostras do sexo masculino, sugestivos de efeito do estresse de manejo sobre o sistema reprodutivo. As concentrações plasmáticas de hormônios gonadotrofinas, gonadais, prolactina e hormônios corticosterona pode ser usado como referência para futuras pesquisas e possíveis abordagens terapêuticas. Os dados médios coletados durante a pesquisa são inéditos para a espécie e pode servir como referência para futuras pesquisas sobre o sistema reprodutivo da tartaruga, também permitindo manejo reprodutivo em cativeiro. Informações sobre esses hormônios devem ser recolhidas a partir de natureza selvagem em diferentes períodos do ano para melhor esclarecimento da fisiologia da reprodução desta espécie.


Subject(s)
Animals , Male , Female , Turtles/physiology , Hormones/blood , Progesterone/blood , Prolactin/blood , Corticosterone/blood , Estradiol/blood
9.
IJRM-International Journal of Reproductive Biomedicine. 2017; 15 (7): 441-446
in English | IMEMR | ID: emr-189257

ABSTRACT

Background: The best time of final oocyte maturation triggering in assisted reproduction technology protocols is unknown. This time always estimated by combined follicular size and blood progesterone level


Objective: The aim of this study was evaluation of the effect of delaying oocyte maturation triggering by 24 hr on the number of mature oocytes [MII] and other in vitro fertilization cycle characteristics in antagonist protocols with not-elevated progesterone [p

Materials and Methods: All patients' candidate for assisted reproduction technology underwent controlled ovarian hyperstimulation by antagonist protocol. When at least 3 follicles with >/=18 mm diameters were seen by vaginal ultrasonography; blood progesterone level was measured. The patients who had progesterone level

Results: Number of retrieved oocytes, mature oocytes [MII], fertilized oocytes [2PN], embryos formation, number of transferred embryos and embryos quality has not significant differences between two groups. Also, fertilization and implantation rate, chemical and clinical pregnancy did not differ between groups


Conclusion: Delaying of triggering oocyte maturation by 24 hr in antagonist protocol with not-elevated progesterone [progesterone

Subject(s)
Humans , Male , Female , Adult , Sperm Injections, Intracytoplasmic , Fertilization in Vitro , Progesterone/blood , Reproductive Techniques, Assisted
10.
Reprod. clim ; 32(1): 24-30, 2017. tab
Article in English | LILACS | ID: biblio-882434

ABSTRACT

Introduction: Pregnancy loss is a common medical problem in reproductive-age as more than fifty percent of human pregnancies are aborted before term. The majority are unrecognized occurring before or with the expected next menses. About 10­12 percent of all clinically diagnosed pregnancies are lost as first-trimester or early second trimester. The rate of fetal death after 14 weeks' gestation is much lower than the rate of pre-embryonic and embryonic loss. CA125 is a member of the mucin family glycoproteins. CA125 has found application as a tumor marker or biomarker that its level may be increased in the serum of some patients with specific types of cancers. Some studies detected that the abortion risk is increased in pregnant women with higher CA125 levels. Progesterone belongs to the C21 group of progestogen. Its main source in humans is the corpus luteum. Human chorionic gonadotropin (HCG) is a glycoprotein produced by syncytiotrophoblast. Aim of the work: The aim of this study was to determine the effectiveness of measuring maternal serum -HCG, progesterone, CA125 in prediction of first trimester abortion. Patients: The study included 90 pregnant women attending the ANC clinic in El-Shatby Maternity University Hospital. Patients were divided equally into two groups: Group I: 45 women with threatened abortion, subdivided into 2 subgroups: Subgroup A ­ Cases ended in abortion; Subgroup B ­ Cases continued as normal pregnancies. Group II: 45 pregnant women with normal pregnancy and were further subdivided into two subgroups: Subgroup C ­ Cases ended in abortion; Subgroup D ­ Cases continued as normal pregnancies. Exclusion criteria: (1) Multiple pregnancies; (2) Anembryonic pregnancy; (3) Pregnant women with prior treatment with progesterone; (4) History of endometriosis; (5) Fibromyoma with pregnancy. Methods: After clinical and sonographic examination, 3 mL venous blood have been taken once for estimation of serum level of -hCG, progesterone and CA125 by quantitative ELISA. Results: This is a case­control study. Out of the 90 pregnancies, 15 cases (16.6%) had aborted during follow-up, 9 cases (60%) of them had history of threatened abortion while 6 cases (40%) had no history of threatened abortion. Regarding Serum Progesterone level between studied groups, the calculated p value was <0.001. For Serum HCG, the calculated p value was <0.001. In Serum CA125 the calculated p value was <0.001.(AU)


Introdução: A perda da gravidez é problema clínico comum em mulheres em idade fértil, pois em mais de 50% das gestações humanas ocorre aborto antes do termo. Em sua maioria, tais abortos passam despercebidos; ocorrem antes da próxima menstruação ou juntamente com a próxima menstruação. Cerca de 10-12% de todos os abortos clinicamente diagnosticados ocorrem no primeiro trimestre ou no início do segundo trimestre. O percentual de mortes fetais após 14 semanas de gestação é muito mais baixo do que o percentual de abortos pré-embrionários ou embrionários. Foi constatado que CA125 tem aplicação como marcador tumoral ou como biomarcador, pois seu nível pode aumentar no soro de alguns pacientes portadores de tipos específicos de neoplasias. CA125 é um membro da família das glicoproteínas mucinas. Alguns estudos observaram que o risco de aborto aumenta em gestantes com níveis mais elevados de CA125. Progesterona pertence ao grupo C21 dos progestágenos. Em seres humanos, sua principal fonte é o corpo lúteo. Gonadotrofina coriônica humana (HCG) é uma glicoproteína produzida pelo sinciciotrofoblasto. Objetivo: Determinar a eficácia da determinação, no soro materno, de -HCG, progesterona e CA125 na previsão do aborto no primeiro trimestre. Pacientes: O estudo abrangeu 90 gestantes atendidas na clínica ANC na Maternidade do Hospital Universitário El-Shatby. As pacientes foram divididas equitativamente em dois grupos. Grupo I: 45 gestantes com ameaça de aborto, subdivididas em dois subgrupos: Subgrupo A ­ Casos que terminaram em aborto; Subgrupo B ­ Casos que tiveram continuidade como gestações normais. Grupo II: 45 gestantes com gestação normal, subdivididas em dois subgrupos: Subgrupo C ­ Casos que terminaram em aborto; Subgrupo D ­ Casos que tiveram continuidade como gestações normais. Critérios de exclusão: 1. Gestações múltiplas; 2. Gestação anembriônica; 3. Gestantes previamente tratadas com progesterona; 4. História de endometriose; 5. Fibromioma com gestação. Métodos: Após exame clínico e ultrassonográfico, 3 mL de sangue venoso foram coletados uma vez para estimar o nível sérico de -hCG, progesterona e CA125 por Elisa quantitativo. Resultados: Este é um estudo de casos-controle. Das 90 gestações, durante o seguimento ocorreram 15 (16,6%) casos de aborto; nove (60%) tinham história de ameaça de aborto, seis (40%) não tinham história de ameaça de aborto. Com relação ao nível sérico de progesterona entre os grupos estudados, calculamos p < 0,001. Para o nível sérico de CA125, calculamos p < 0,001.(AU)


Subject(s)
Humans , Female , Pregnancy , Adult , Young Adult , Abortion , Biomarkers/blood , CA-125 Antigen/blood , Chorionic Gonadotropin, beta Subunit, Human/blood , Pregnancy Trimester, First , Progesterone/blood
11.
Rev. biol. trop ; 64(4): 1519-1526, oct.-dic. 2016. ilus
Article in English | LILACS | ID: biblio-958231

ABSTRACT

Abstract:The agouti (Dasyprocta sp.) is a hystricomorph rodent found in some regions of the Americas. It is an important cynegetic species, which indicates that the overhunting is a threat to their conservation. Very little is known about this wildlife in relation to what already has been studied in domestic animals. Thus, the knowledge on reproduction of wildlife becomes necessary and essential for the management and conservation of these natural resources. Specifically, studies regarding hormonal monitoring are important as a basic tool for research in modern reproductive biotechnology, and currently, there is no information on the progesterone changes during pregnancy of Dasyprocta sp., compared to other hystricomorphs. The aim of this study was to describe the profile of plasmatic progesterone during pregnancy, and report the restart of ovarian cycle in agouti after parturition. For this purpose, 18 black-rumped agoutis (Dasyprocta prymnolopha) born in captivity were used, and one or more consecutive pregnancies were observed. Copulation was confirmed by the presence of spermatozoa observed in the colpocytological examination. Blood samples were collected two times per week, and concentrations of progesterone, assessed in ten agoutis, were determined by radioimmunoassay. The onset of ovarian activity in six females was observed daily by colpocytological examination, starting on the seventh day postpartum. The gestational period observed in this study was 104.04 days (SD = 1.31) (101-106 days) (Number of cases, N = 26), and the interval between births was 126.03 days (SD = 18.40) (109-184 days). The plasmatic profile of progesterone during pregnancy showed a progressive increase from the 1st to the 5th week. The higher progesterone levels over this period (6.88 ng / mL, SD = 3.01) were detected in the 5th week. This value was similar (One-Way ANOVA, p > 0.05) to that observed in the 4th and 6th weeks, but was statistically different (One-Way ANOVA, p < 0.05) when compared to the other weeks. After the 6th week there was a progressive decrease in plasmatic progesterone levels. The animals showed a postpartum estrus of 12.04 days (SD= 4.29) (7-24 days) (N= 23). It was observed that 80.95 % (N= 19) of copulations during this period were fertile. This work contributed to understanding the dynamic changes in the progesterone levels during the pregnancy in agouti. Nevertheless, more studies are needed for a better appreciation of other endocrine and biological changes, in the mother and feto-placental unit of the agouti. Rev. Biol. Trop. 64 (4): 1519-1526. Epub 2016 December 01.


Resumen:El agouti (Dasyprocta sp.) es un roedor histricomorfo encontrado en algunas regiones de América. Es una especie cinegética importante, lo que indica que la caza excesiva es una amenaza para su conservación. Muy poco es lo que se conoce acerca de la biología de los animales silvestres, en relación al conocimiento acumulado sobre los domésticos. Por lo tanto, el estudio sobre la reproducción de los animales silvestres se hace necesario e imprescindible para el manejo y conservación de la especie como recurso natural. En concreto, los estudios relativos a la monitorización hormonal son una herramienta básica para la investigación en biotecnología reproductiva moderna. No hay información sobre los cambios de progesterona durante la preñez de Dasyprocta sp. en comparación con otros histricomorfos. El objetivo de este estudio fue describir el perfil de la progesterona plasmática durante la preñez, y reportar el reinicio del ciclo ovárico después del parto. Para ello, se utilizaron 18 agoutis de rabo negro (Dasyprocta prymnolopha) nacidos en cautiverio. Fueron estudiadas una o más preñeces consecutivas. La copulación fue confirmada por la presencia de espermatozoides observados en examen colpocitológico. Las muestras de sangre se recogieron dos veces por semana, y las concentraciones de progesterona se determinaron en 10 individuos mediante radioinmunoensayo. Se observó el inicio de la actividad ovárica diaria por examen colpocitológico, comenzando en el día séptimo posparto. El período gestacional observado en este estudio fue de 104.04 días (SD= 1.31, rango entre 101-106 días, N= 26), y el intervalo entre los nacimientos fue 126.03 días (SD= 18.40, rango entre 109-184 días). El perfil plasmático de la progesterona durante el embarazo mostró un aumento progresivo de la 1ª a la 5ª semana. Los mayores niveles de progesterona durante este período (6.88 ng / mL, SD= 3.01) se detectaron en la quinta semana. Este valor fue similar (ANOVA de um factor, p > 0.05) al observado en las semanas cuatro y seis, pero fue estadísticamente diferente (ANOVA de um factor, p<0.05) en comparación con las otras semanas. Después de la sexta semana hubo una disminución progresiva en los niveles plasmáticos de progesterona. Los animales mostraron un estro posparto de 12.04 días (SD= 4.29, rango entre 7-24 días, N= 23). Se observó que el 80.95 % (N= 19) de cópulas durante este período fueron fértiles. Este trabajo contribuyó a la comprensión de los cambios dinámicos en los niveles de progesterona durante la preñez del agouti. Sin embargo, se necesitan más estudios para una mejor comprensión de otros cambios biológicos y endocrinos, y en la unidad materna y feto-placentaria del agouti.


Subject(s)
Animals , Pregnancy , Progesterone/blood , Estrus/blood , Postpartum Period/blood , Dasyproctidae/blood , Reference Values , Sexual Behavior, Animal/physiology , Time Factors , Analysis of Variance , Gestational Age
12.
Acta cir. bras ; 31(4): 278-285, Apr. 2016. tab, graf
Article in English | LILACS | ID: lil-781333

ABSTRACT

PURPOSE: To investigate gender differences in the evolution of the inflammatory process in rats subjected to brain death (BD). METHODS: Adult Wistar rats were divided into three groups: female; ovariectomized female; and male rats. BD was induced using intracranial balloon inflation and confirmed by maximal pupil dilatation, apnea, absence of reflex, and drop of mean arterial pressure. Six hours after BD, histological evaluation was performed in lungs, heart, liver and kidneys, and levels of inflammatory proteins, estrogen, progesterone, and corticosterone were determined in plasma. RESULTS: In the lungs, females presented more leukocyte infiltration compared to males (p<0.01). Ovariectomized female rat lungs were more hemorrhagic compared to other groups (p<0.001). In the heart, females had higher leukocyte infiltration and tissue edema compared to males (p<0.05). In the liver and kidneys, there were no differences among groups. In female group estradiol and progesterone were sharply reduced 6 hours after BD (p<0.001) to values observed in ovariectomized females and males. Corticosterone levels were similar. CONCLUSIONS: Sex hormones influence the development of inflammation and the status of organs. The increased inflammation in lungs and heart of female rats might be associated with the acute reduction in female hormones triggered by BD.


Subject(s)
Animals , Male , Female , Brain Death/pathology , Sex Characteristics , Kidney/pathology , Liver/pathology , Lung/pathology , Myocardium/pathology , Organ Specificity , Progesterone/blood , Reference Values , Time Factors , Ovariectomy , Sex Factors , Rats, Wistar , Edema/pathology , Estradiol/blood , Chemokine CXCL1/analysis , Chemokine CXCL2/analysis , Inflammation/pathology
13.
Acta cir. bras ; 31(4): 286-293, Apr. 2016. tab, graf
Article in English | LILACS | ID: lil-781334

ABSTRACT

PURPOSE: To evaluate the effects of letrozole (Ltz) in carcinogen+estrogen-induced endometrial hyperplasia. METHODS: BALB/c female mice were divided into four groups of 12 animals each receiving an intrauterine dose of N-ethyl-N-nitrosourea (ENU) and weekly subcutaneous injections of estradiol hexaidrobenzoate (EHB), except for group I(control). The groups were divided in I (control), II (ENU+EHB), III (ENU+EHB+MPA) and IV (ENU+EHB+Ltz). Group III also received intramuscular injections of MPA (medroxy progesterone acetate) every four weeks, while group IV received oral doses of Ltz daily. At the end of 16 weeks, the animals were sacrificed, and blood samples were collected for the measurement of serum estradiol and progesterone levels. Uterine histological sections were made to evaluate the presence of endometrial proliferative lesions. Differences between groups were evaluated with student's t test, ANOVA and chi-square test. RESULTS: Groups ENU+EHB, ENU+EHB+MPA and ENU+EHB+Ltz showed varying degrees of endometrial hyperplasia. The incidence of hyperplasia in groups ENU+EHB and ENU+EHB+Ltz was higher and more severe than in group ENU+EHB+MPA. Control group showed lower levels of serum estradiol than the other groups. CONCLUSION: There was no evidence that letrozole could act as an antiestrogenic drug in the development of endometrial proliferative lesions.


Subject(s)
Animals , Female , Triazoles/pharmacology , Aromatase Inhibitors/pharmacology , Endometrial Hyperplasia/drug therapy , Carcinogenesis/drug effects , Nitriles/pharmacology , Progesterone/blood , Time Factors , Triazoles/therapeutic use , Adenocarcinoma/etiology , Adenocarcinoma/drug therapy , Reproducibility of Results , Treatment Outcome , Endometrial Neoplasms/etiology , Endometrial Neoplasms/drug therapy , Medroxyprogesterone Acetate/pharmacology , Antineoplastic Agents, Hormonal/pharmacology , Aromatase Inhibitors/therapeutic use , Endometrial Hyperplasia/chemically induced , Endometrial Hyperplasia/pathology , Endometrium/drug effects , Endometrium/pathology , Estradiol/blood , Ethylnitrosourea , Carcinogenesis/pathology , Mice, Inbred BALB C , Nitriles/therapeutic use
14.
Reprod. clim ; 31(3): 134-142, 2016. ilus, tab, graf
Article in Portuguese | LILACS | ID: biblio-881002

ABSTRACT

Introdução: Múltiplos estudos sugerem que os valores de ß-hCG e de progesterona podem ser bons preditores de gravidez. Objetivo: Investigar o potencial dos valores de ß-hCG e progesterona na previsão de gravidez evolutiva e de gravidez gemelar, 14 dias após punção ovocitária em ciclos FIV/ICSI, e estabelecer um modelo de previsão. Métodos: Estudo retrospetivo de ciclos com punção e transferência de embriões a fresco entre maio/2011 e setembro/2015. Os grupos definidos foram: sem gravidez; gravidez não evolutiva; gravidez evolutiva (única ou gemelar). A análise estatística considerou = 5%. Para avaliar a capacidade de prever gravidez evolutiva e gravidez gemelar recorreu-se a um modelo de análise multivariada e usou-se um processo de regressão logística binária. Recorreu-se às curvas ROC para avaliar a capacidade do valor de ß-hCG e progesterona na distinção entre gravidez não evolutiva e evolutiva. Resultados: Verificaram-se 149 casos: sem gravidez 11,4%, gravidez não evolutiva 24,8%, gravidez evolutiva 63,8% (83 única, 12 gemelares). Com exceção dos valores de progesterona e ß-hCG, não se verificaram diferenças estatisticamente significativas entre as variáveis do grupo gravidez não evolutiva e evolutiva (ß-HCG: 38,9 vs 159 UI/L; progesterona: 20,4 vs 60 ng/mL). Na comparac¸ão entre gravidez única e gemelar, apenas o valor de ß-hCG foi estatisticamente significativo (ß-HCG: 147 vs 331 UI/L). Quando o valor de progesterona é ≥ 25, a probabilidade de gravidez é 5,4 vezes superior (IC95%, 1,18-24,8). Na regressão logística para gravidez gemelar apenas o valor de ß-hCG foi estatisticamente significativo. Conclusão: Uma avaliação única de progesterona e ß-hCG, 14 dias após punção, tem um bom valor preditivo de gravidez evolutiva, porém com capacidade limitada para discriminar entre gravidez única e gemelar.(AU)


Introduction: Multiple studies suggest that the amount of ß-hCG and progesterone can be good predictors of pregnancy. Objective: To investigate the potential of ß-hCG and progesterone values in predicting evolutive pregnancy and twin pregnancy, 14 days after oocyte puncture in IVF/ICSI cycles, establishing a predictive model. Methods: A retrospective study of cycles with the use of a puncture and fresh embryo transfer between May/2011 and September/2015. The defined groups were: with no pregnancy; without evolutive pregnancy; and with evolutive (single or twin) pregnancy. Statistical analysis considered = 5%. To assess the ability to predict evolutive pregnancy and twin pregnancy, a multivariate analysis model was carried out, with the use of a binary logistic regression process. ROC curves were used to evaluate the ability of ß-hCG and progesterone values in differentiating between non-evolutive and evolutive pregnancy. Results: 149 cases were found: no pregnancy 11.4%, without evolutive pregnancy 24.8%, with evolutive pregnancy 63.8% (83 single, 12 twins). Excluding progesterone and ß-hCG values, there were no statistically significant differences between the variables of non-evolutive and evolutive pregnancy groups (ß-HCG: 38.9 vs. 159 IU/L, progesterone: 20.4 vs. 60ng/mL). In a comparison between single and twin pregnancies, only the amount of ß-hCG was statistically significant (ß-HCG: 147 vs. 331 IU/L). When progesterone value is >25, the probability of pregnancy is 5.4 times greater (95% CI, 1.18-24.8). In a logistic regression for twin pregnancies, only ß-hCG value was statistically significant. Conclusion: A single assessment of progesterone and ß-hCG values 14 days after the puncture has a good predictive value of evolutive pregnancy, but with limited ability to discriminate between single and twin pregnancies.(AU)


Subject(s)
Humans , Female , Adult , Chorionic Gonadotropin, beta Subunit, Human/blood , Fertilization in Vitro/methods , Pregnancy, Twin/statistics & numerical data , Progesterone/blood
15.
Clinics ; 70(9): 632-637, Sept. 2015. tab, ilus
Article in English | LILACS | ID: lil-759286

ABSTRACT

OBJECTIVE:To quantify the collagen fibers in the lacrimal gland of female mice with hyperprolactinemia.METHODS:Forty adult female mice were randomly divided into two groups with 20 animals each: nonpregnant control (CTR1, control group, 0.2 mL of saline solution) and nonpregnant experimental (HPRL1, experimental group, 200 µg/day metoclopramide). Treatments lasted for 50 consecutive days. On day 50, 10 females from each group (control and experimental) were euthanized in the proestrus phase; then, the blood was collected and the lacrimal glands were removed. Thereafter, the remaining females were placed with the mates and continued to receive treatment with saline solution or metoclopramide. On the 6th post-coital day, 10 pregnant females from the control group (CTR2) and 10 pregnant females from the experimental group (HPRL2) were euthanized, after which blood was collected and the lacrimal glands removed. The lacrimal glands were processed for morphological analyses and collagen quantification, and prolactin and sex steroid levels were measured in the blood samples. Data were statistically analyzed using an unpaired Student t test (p<0.05).RESULTS:Morphological analysis revealed greater structural tissue disorganization of the lacrimal glands in the metoclopramide-treated groups. The total collagen content was significantly higher in the HPRL1 group than in the CTR1 group (p<0.05), whereas the difference between the CTR2 and HPRL2 groups was not significant.CONCLUSION:Our data suggest an impairment in the functioning of the lacrimal gland as a consequence of increased prolactin levels and decreased serum levels of estrogen and progesterone.


Subject(s)
Animals , Female , Mice , Pregnancy , Collagen/drug effects , Hyperprolactinemia/chemically induced , Lacrimal Apparatus/drug effects , Collagen/analysis , Estradiol/blood , Hyperprolactinemia/blood , Hyperprolactinemia/pathology , Lacrimal Apparatus/pathology , Metoclopramide , Proestrus/blood , Progesterone/blood , Prolactin/blood , Radioimmunoassay , Random Allocation
16.
IPMJ-Iraqi Postgraduate Medical Journal. 2015; 14 (1): 7-13
in English | IMEMR | ID: emr-159902

ABSTRACT

Prompt diagnosis of ectopic pregnancy is a difficult dilemma, and reliable predictors for diagnosis and differentiation of ectopic pregnancy from early pregnancy miscarriage are needed. To evaluate the diagnostic value of serum progesterone and CA-125 levels in ectopic pregnancy and early intra uterine miscarriage. A prospective case control study. The study was carried out in the department of obstetrics and gynecology of AL-Yarmouk teaching hospital [Baghdad - Iraq] from February 2011 to February 2012. This study was carried out on sixty pregnant women in their first trimester. Twenty women diagnosed as unruptured ectopic pregnancy; treated by laparotomy, twenty women diagnosed as inevitable miscarriage; treated by curettage and twenty women with healthy pregnancy of a comparable gestational age as control group; follow up of this group was done to ascertain uneventful pregnancy with no complications. We compared the serum levels of progesterone and CA-125 in all groups at the time of presentation and 24h after surgical intervention in first and second groups. There was a significant decrease in mean post operative progesterone level in women with ectopic pregnancy and miscarriage groups with significant difference [P<0.0001]. The study observed that the mean level of progesterone in women with ectopic group [6.76 +/- 3.63 ng/ml] was lower than that in miscarriage group [15.17 +/- 6.01 ng/ml] and control group [17.58 +/- 4.57 ng/ml] with significant difference [P<0.0001]. This study also observed that the mean level of CA-125 in women with miscarriage group [117.07 +/- 94.30 U/ml] was higher than that in ectopic group [38.11 +/- 28.79 U/ml] and control group [30.51 +/- 16.10 U/ml] with statistically significant difference [P<0.0001]. There was a significant decrease in mean level of post operative CA-125 in women with ectopic pregnancy and miscarriage groups with significant difference [P<0.0003]. Combined measurement of both serum progesterone and CA-125 can be sensitive predictors in diagnosis and differentiation of ectopic pregnancy from inevitable miscarriage and normal pregnancy


Subject(s)
Humans , Female , Progesterone/blood , Membrane Proteins , CA-125 Antigen/blood , Case-Control Studies , Abortion, Spontaneous , Pregnancy
17.
Braz. j. med. biol. res ; 47(6): 505-514, 06/2014. tab, graf
Article in English | LILACS | ID: lil-709447

ABSTRACT

Cocaine sensitization is a marker for some facets of addiction, is greater in female rats, and may be influenced by their sex hormones. We compared the modulatory effects of endogenous or exogenous estradiol and progesterone on cocaine-induced behavioral sensitization in 106 female rats. Ovariectomized female rats received progesterone (0.5 mg/mL), estradiol (0.05 mg/mL), progesterone plus estradiol, or the oil vehicle. Sham-operated control females received oil. Control and acute subgroups received injections of saline, while the repeated group received cocaine (15 mg/kg, ip) for 8 days. After 10 days, the acute and repeated groups received a challenge dose of cocaine, after which locomotion and stereotypy were monitored. The estrous cycle phase was evaluated and blood was collected to verify hormone levels. Repeated cocaine treatment induced overall behavioral sensitization in female rats, with increased locomotion and stereotypies. In detailed analysis, ovariectomized rats showed no locomotor sensitization; however, the sensitization of stereotypies was maintained. Only females with endogenous estradiol and progesterone demonstrated increased locomotor activity after cocaine challenge. Estradiol replacement enhanced stereotyped behaviors after repeated cocaine administration. Cocaine sensitization of stereotyped behaviors in female rats was reduced after progesterone replacement, either alone or concomitant with estradiol. The behavioral responses (locomotion and stereotypy) to cocaine were affected differently, depending on whether the female hormones were of an endogenous or exogenous origin. Therefore, hormonal cycling appears to be an important factor in the sensitization of females. Although estradiol increases the risk of cocaine sensitization, progesterone warrants further study as a pharmacological treatment in the prevention of psychostimulant abuse.


Subject(s)
Animals , Female , Central Nervous System Sensitization/drug effects , Cocaine/pharmacology , Estradiol/blood , Motor Activity/drug effects , Progesterone/blood , Stereotyped Behavior/drug effects , Analysis of Variance , Cocaine/administration & dosage , Estradiol/pharmacology , Estrous Cycle/blood , Hormone Replacement Therapy , Ovariectomy , Progesterone/pharmacology , Rats, Wistar , Sex Factors
18.
Journal of Veterinary Science ; : 343-352, 2014.
Article in English | WPRIM | ID: wpr-194864

ABSTRACT

Cows with different Insulin-like Growth Factor-I (IGF-I) concentrations showed comparable expression levels of hepatic growth hormone receptor (GHR). Suppressor of cytokine signaling 2 (SOCS2), could be responsible for additional inhibition of the GHR signal cascade. The aims were to monitor cows with high or low antepartal IGF-I concentrations (IGF-I(high) or IGF-I(low)), evaluate the interrelationships of endocrine endpoints, and measure hepatic SOCS2 expression. Dairy cows (n = 20) were selected (240 to 254 days after artificial insemination (AI)). Blood samples were drawn daily (day -17 until calving) and IGF-I, GH, insulin, thyroid hormones, estradiol, and progesterone concentrations were measured. Liver biopsies were taken (day 264 +/- 1 after AI and postpartum) to measure mRNA expression (IGF-I, IGFBP-2, IGFBP-3, IGFBP-4, acid labile subunit (ALS), SOCS2, deiodinase1, GHR1A). IGF-I concentrations in the two groups were different (p 0.05). Thyroxine levels and ALS expression were higher in the IGF-I(high) cows compared to IGF-I(low) cows. Estradiol concentration tended to be greater in the IGF-I(low) group (p = 0.06). It was hypothesized that low IGF-I levels are associated with enhanced SOCS2 expression although this could not be decisively confirmed by the present study.


Subject(s)
Animals , Cattle , Female , Estradiol/blood , Growth Hormone/blood , Insulin/blood , Insulin-Like Growth Factor Binding Protein 2/analysis , Insulin-Like Growth Factor Binding Protein 3/analysis , Insulin-Like Growth Factor Binding Protein 4/analysis , Insulin-Like Growth Factor I/analysis , Liver/chemistry , Pregnancy/metabolism , Pregnancy, Animal/metabolism , Progesterone/blood , Suppressor of Cytokine Signaling Proteins/analysis , Thyroid Hormones/blood
19.
Journal of Veterinary Science ; : 427-432, 2014.
Article in English | WPRIM | ID: wpr-194854

ABSTRACT

The reliability of a Korean black goat (Capra hircus coreanae) to detect estrus in Himalayan tahrs (Hemitragus jemlahicus) for an artificial breeding program was investigated. Estrus in six female Himalayan tahrs was synchronized using fluorogestone acetate (FGA) sponges. Thirteen days later, 200 IU of PMSG and 100 IU of hCG were injected before removing the sponges and simultaneously injecting 5 mg of PGF2alpha the next day. Penetration of the cervical canal and the thickness and location of red crayon marks were examined 40~43 h later. Two females treated with sponges containing 60 or 45 mg of FGA had estrogen levels of 8.7 and 11.1 pg/mL, respectively. No red marks were found on the backs of these two tahrs. The remaining females had higher levels of estradiol, and the red crayon marks were clearly shown. The cervical folds of these tahrs were readily penetrated and the insemination gun was smoothly inserted into the uterine body. In conclusion, a Korean domestic goat with its chest crayon-harnessed was successfully used to detect estrus of Himalayan tahrs. This technique might be utilized as a part of breeding programs for wild goats and avoid the need for a vasectomy of conspecific males.


Subject(s)
Animals , Female , Male , Breeding/methods , Estradiol/blood , Estrus/physiology , Estrus Detection/methods , Estrus Synchronization/methods , Goats/physiology , Progesterone/blood
20.
Journal of Veterinary Science ; : 167-171, 2014.
Article in English | WPRIM | ID: wpr-56419

ABSTRACT

The level of P4 at the time of embryo transfer (ET) is important. P4 concentrations and numbers of corpora lutea for 126 recipients were evaluated. Nuclear transfer embryos were transferred into 126 surrogates. 11 maintained their pregnancy until full-term delivery, 17 miscarried, and implantation failed in 98 animals. P4 levels in the full-term group were significantly different from those of the pigs that aborted or in which implantation failed (p < 0.05). However, the numbers of corpora lutea were not significantly different. These findings indicate that the concentration of progesterone can be an important factor for successful ET in pigs.


Subject(s)
Animals , Female , Pregnancy , Corpus Luteum/physiology , Embryo Transfer/veterinary , Embryo, Mammalian/physiology , Nuclear Transfer Techniques , Pregnancy Rate , Progesterone/blood , Retrospective Studies , Sus scrofa/physiology
SELECTION OF CITATIONS
SEARCH DETAIL